<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 17:14:38" record="38523" source="Espacenet">
	<entities>
		<entity ref="Patent38523" type="Patent">
			<semanticIdentifier>brcris::dfe77d1dd0a907a3bf0ebc2e97798a9c</semanticIdentifier>
			<semanticIdentifier>docdb::BR102013022376A2</semanticIdentifier>
			<semanticIdentifier>epodoc::BR102013022376</semanticIdentifier>
			<semanticIdentifier>docdb::BR102013022376A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR20131022376</semanticIdentifier>
			<semanticIdentifier>original::102013022376</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=102013022376"/>
			<field name="identifier.lattes" value="9148354106985023"/>
			<field name="identifier.espacenet" value="102013022376"/>
			<field name="kindCode" value="A2"/>
			<field name="title.espacenet" value="trypanosoma cruzi recombinante e composição vacinal para profilaxia de leishmanioses"/>
			<field name="title.lattes" value="TRYPANOSOMA CRUZI RECOMBINANTE E COMPOSIÇÃO VACINAL PARA PROFILAXIA DE LEISHMANIOSES"/>
			<field name="depositDate" value="2013-09-02"/>
			<field name="publicationDate" value="2016-08-09"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="ANA PAULA SALLES MOURA FERNANDES"/>
			<field name="inventor" value="CAROLINE JUNQUEIRA GIUSTA"/>
			<field name="inventor" value="DANIEL HENRIQUE PEREIRA DORO"/>
			<field name="inventor" value="RICARDO TOSTES GAZZINELLI"/>
			<field name="applicant" value="UNIVERSIDADE FEDERAL DE MINAS GERAIS"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="A61K39/008AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="39"/>
				<field name="subgroup" value="008AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61P33/02AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="33"/>
				<field name="subgroup" value="02AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="3"/>
				<field name="text" value="C12N1/11AI"/>
				<field name="section" value="C"/>
				<field name="class" value="12"/>
				<field name="subclass" value="N"/>
				<field name="group" value="1"/>
				<field name="subgroup" value="11AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="4"/>
				<field name="text" value="C12N15/30AI"/>
				<field name="section" value="C"/>
				<field name="class" value="12"/>
				<field name="subclass" value="N"/>
				<field name="group" value="15"/>
				<field name="subgroup" value="30AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="5"/>
				<field name="text" value="C12R1/90AN"/>
				<field name="section" value="C"/>
				<field name="class" value="12"/>
				<field name="subclass" value="R"/>
				<field name="group" value="1"/>
				<field name="subgroup" value="90AN"/>
			</field>
			<field name="abstract.espacenet" value="trypanosoma cruz! recombinante e composição vacinal para profilaxia de leishmanioses a presente invenção descreve a cepa não-virulenta cl-14 de trypanosoma cruzi transfectada com um vetor integrativo contendo um gene sintético otimizado da proteína a2 de leishmania (seq id n01), bem como uma composição vacinal que a contém e os usos ,do t. cruzi recombinante e da com~osiçáo vacinal. a imunização com a construção cl-1 4 a2 potencializou a respbsta celular ao antígeno a2 e peptídeos derivados, associada às células t 0d4+ e cd8+, com elevada produção de ifn-y, e foi capaz de induzir proteção parcial em camundongos balb/c, contra a infecção por l. infantum. portanto, a estratégia utilizada representa uma abordagem capaz de potencializar imunogenicidade e proteção contra ieishmaniose visceral, sendo uma estratégia alternativa para o desenvolvimento de composições vacinais. além disso, a construção cl-1 4 a2 viabiliza a produção de proteína recombinante em células eucariontes para testes em diagnóstico."/>
			<field name="originatesFrom" value="56565066"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102013022376"/>
				<field name="kind" value="A2"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR102013022376"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102013022376"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR20131022376"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value=""/>
				<field name="number" value="102013022376"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Person26508" type="Person">
			<semanticIdentifier>lattes::9148354106985023</semanticIdentifier>
			<field name="identifier.lattes" value="9148354106985023"/>
			<field name="name" value="Ricardo Tostes Gazzinelli"/>
		</entity>
		<entity ref="OrgUnit20787" type="OrgUnit">
			<semanticIdentifier>brcris::b325025cd443a1ebf025d67185ebad24</semanticIdentifier>
			<field name="name" value="UNIVERSIDADE FEDERAL DE MINAS GERAIS"/>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent38523" toEntityRef="Person26508" type="Inventor"/>
		<relation fromEntityRef="Patent38523" toEntityRef="OrgUnit20787" type="Applicant"/>
	</relations>
</entity-relation-data>
